Vantage Consulting Group’s ICU Medical ICUI Stock Holding History

Vantage Consulting Group’s Portfolio ICUI Stock Details ICUI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-18	Closed	-$4K	–	782
2020 Q4	$4K	Buy	+18	New	+$3.49K	﹤0.01%	1492

Other funds holding ICUI

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Nuance Investments Kansas City, Missouri $717M AUM 3.8% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

FPP

Findlay Park Partners London, United Kingdom $7.17B AUM 17.27% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

ACM

Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return

Vantage Consulting Group's ICUI Position: Q1 2021 in Review

Vantage Consulting Group sold out of ICU Medical (ICUI) in Q1 2021, closing a stake of 18 shares — an estimated $4K sold.

Vantage Consulting Group first reported a position in ICUI in Q4 2020 and held it in 1 quarter. The position peaked at $4K in Q4 2020. 288 funds tracked by Wall St. Rank hold ICUI as of Q1 2021.

Vantage Consulting Group reported no remaining ICU Medical position as of Q1 2021 after selling out during the quarter.
Vantage Consulting Group sold 18 ICU Medical shares in Q1 2021, an estimated $4K.
Vantage Consulting Group first reported a position in ICU Medical in Q4 2020 and held it in 1 quarter.
Vantage Consulting Group's ICU Medical position peaked at $4K in Q4 2020.
288 funds tracked by Wall St. Rank held ICU Medical as of Q1 2021.

Based on Vantage Consulting Group's 13F filing for Q1 2021, filed 14 May 2021.